{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00422058","recordId":"NCT00422058","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00422058-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00422058.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00422058.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2007-01-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2007-01-12","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"611e2f5ba142ecaf5eea2fcd4a0dc4a38e9ca727ec4026e416675265bf8b6e32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2007-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2007-04-27","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"731ab8f6e0130a02ce8dab8b87a34c708b2fe89e30a44b0d146c4ea27d755f3f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Oversight","References","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2007-09-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2007-09-28","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"c90198d4c51f24c62853049ef003cc1628835ef8e7b308cdadc5cd2af2260c01","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Design","Study Identification","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2008-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2008-09-16","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"9557ff7e2fccfeb48af1f3fa2775c81e1af40c47ea0ea0d9003801dff3e53f1b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2009-06-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2009-06-11","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"ef696647e94b441c2a95a06395f4972f305b8830962fe2c8fbf63aea39d6e1f5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2010-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2010-10-05","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"8bff7ad48e9877e202fd3817bfe910ccb244d02c19df914fb56e3f8802356837","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2010-11-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2010-11-23","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"06d20dadae14b2bba3102f4f8c3fcd077fc138fec8c3e85d108b6e18642e4e54","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2011-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2011-02-14","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"5257bc54bb2dcd8ca80bb6c9ca791217775aff7ac859108c055b4da1a122a644","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2012-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2012-06-26","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"fb23717110d4cf17728d9785eb296210341077ef2edc4f65170662b04bc6be22","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2015-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2015-04-22","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"f841eb42779f64de32d8b6ff989d603a9f31fb915f6ef989967b3fe07fde4cdf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","References","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-02-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-02-09","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"37562113eeb1c1298bbf95b782066c1b6ad18358488b3808658aeb4e11fd0dda","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Oversight","References","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-05-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-05-17","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"58c1548c223215a4e2ec142177b8e618237bf16eebfbd7eb444b065885b320eb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2017-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2017-09-29","publishedAt":"2026-08-23","recordId":"NCT00422058","recordSha256":"56fc517b1d5010adbf5f87cc18070fb36aae39a1fde22e4ff2c5a154291e21ca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00422058?a=13&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"7c7e6d3ed702611ae74d2ba24a6e1a71c8930122bcda4b9daa09cb6d74ce235f"}}